Abstract
Background
Vancomycin prescription and monitoring guidelines have been reported to be poorly followed by various centers.
Aims
Identifying barriers to compliance with vancomycin dosing and therapeutic drug monitoring guidelines (TDM) and possible ways to enhance compliance based on the healthcare providers’ (HCPs) perspective.
Methods
A qualitative study based on semi-structured interviews with HCP (physicians, pharmacists, and nurses) was conducted at two Jordanian Teaching Hospitals. Interviews were audio-recorded and analyzed through thematic analysis. The COREQ criteria for qualitative research were utilized to report the study findings.
Results
A total of 34 HCPs were interviewed. HCP perceived several factors as barriers to guideline recommendation compliance. Such factors included negative perception towards prescription guidelines, lack of knowledge regarding TDM guidelines, the hierarchy of medication management, work pressure, and ineffective communication among healthcare providers. Potential strategies to optimize guidelines adaptation included providing HCPs with more training and decision support tools in addition to activating the role of clinical pharmacists.
Conclusions
The main barriers to guideline recommendations uptake were identified. Interventions should address those barriers related to the clinical environment, including enhancing interprofessional communication related to vancomycin prescription and TDM, reducing workload and providing support systems, promoting educational and training programs, in addition to adopting guidelines suitable for the local environment.
Funder
Deanship of Scientific Research University of Jordan
Publisher
Public Library of Science (PLoS)
Reference25 articles.
1. Children may need higher vancomycin doses to achieve therapeutic levels;K Oskarsdottir;Acta Paediatr,2021
2. Achieving Vancomycin Troughs Within Goal Range in Low Birth Weight Neonates;SB Stone;J Pediatr Pharmacol Ther,2021
3. Plasma and interstitial fluid population pharmacokinetics of vancomycin in critically ill patients with sepsis;J Abraham;Int J Antimicrob Agents,2019
4. Automating Vancomycin Monitoring to Improve Patient Safety;V Mishra;Jt Comm J Qual Patient Saf,2019
5. Vancomycin therapeutic drug monitoring in paediatrics;J Patel;J Paediatr Child Health,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献